Eastman Chemical Company $EMN Shares Bought by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC increased its position in shares of Eastman Chemical Company (NYSE:EMNFree Report) by 171.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 62,939 shares of the basic materials company’s stock after acquiring an additional 39,717 shares during the quarter. Campbell & CO Investment Adviser LLC owned approximately 0.05% of Eastman Chemical worth $4,699,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB grew its stake in shares of Eastman Chemical by 65.5% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 369 shares of the basic materials company’s stock valued at $28,000 after buying an additional 146 shares during the period. Ameritas Advisory Services LLC purchased a new position in Eastman Chemical in the 2nd quarter worth approximately $32,000. National Pension Service grew its holdings in Eastman Chemical by 75.3% during the 1st quarter. National Pension Service now owns 433 shares of the basic materials company’s stock valued at $38,000 after purchasing an additional 186 shares in the last quarter. TD Private Client Wealth LLC grew its stake in shares of Eastman Chemical by 46.4% during the first quarter. TD Private Client Wealth LLC now owns 536 shares of the basic materials company’s stock valued at $47,000 after acquiring an additional 170 shares in the last quarter. Finally, Hilltop National Bank acquired a new stake in Eastman Chemical during the 2nd quarter valued at approximately $62,000. Hedge funds and other institutional investors own 83.65% of the company’s stock.

Eastman Chemical Stock Performance

Shares of EMN opened at $61.25 on Friday. Eastman Chemical Company has a one year low of $56.75 and a one year high of $107.50. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.68 and a quick ratio of 0.78. The stock has a market cap of $7.03 billion, a price-to-earnings ratio of 8.60, a PEG ratio of 6.16 and a beta of 1.31. The company has a 50-day moving average of $63.43 and a two-hundred day moving average of $71.22.

Eastman Chemical (NYSE:EMNGet Free Report) last released its earnings results on Monday, November 3rd. The basic materials company reported $1.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.04). The business had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.28 billion. Eastman Chemical had a net margin of 8.96% and a return on equity of 15.24%. Eastman Chemical’s revenue for the quarter was down 10.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.26 EPS. Eastman Chemical has set its FY 2025 guidance at 5.400-5.65 EPS. On average, equities research analysts expect that Eastman Chemical Company will post 8.55 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on EMN shares. Bank of America dropped their price target on shares of Eastman Chemical from $78.00 to $74.00 and set a “buy” rating for the company in a research note on Tuesday, October 14th. KeyCorp set a $79.00 price target on shares of Eastman Chemical and gave the company an “overweight” rating in a report on Monday, August 4th. Royal Bank Of Canada set a $71.00 price objective on Eastman Chemical in a research note on Tuesday, October 14th. UBS Group decreased their target price on shares of Eastman Chemical from $75.00 to $73.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, Mizuho decreased their price target on Eastman Chemical from $80.00 to $75.00 and set an “outperform” rating for the company in a research note on Friday, October 3rd. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $79.33.

Get Our Latest Research Report on EMN

Eastman Chemical Company Profile

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Recommended Stories

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.